about
PET imaging of recurrent and metastatic prostate cancer with novel tracers.Initial single-centre Canadian experience with 18F-fluoromethylcholine positron emission tomography-computed tomography (18F-FCH PET/CT) for biochemical recurrence in prostate cancer patients initially treated with curative intentHallmarks in prostate cancer imaging with Ga68-PSMA-11-PET/CT with reference to detection limits and quantitative properties.
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The Utility of Molecular Imaging in Prostate Cancer
@ast
The Utility of Molecular Imaging in Prostate Cancer
@en
The Utility of Molecular Imaging in Prostate Cancer
@nl
type
label
The Utility of Molecular Imaging in Prostate Cancer
@ast
The Utility of Molecular Imaging in Prostate Cancer
@en
The Utility of Molecular Imaging in Prostate Cancer
@nl
prefLabel
The Utility of Molecular Imaging in Prostate Cancer
@ast
The Utility of Molecular Imaging in Prostate Cancer
@en
The Utility of Molecular Imaging in Prostate Cancer
@nl
P2093
P2860
P1476
The Utility of Molecular Imaging in Prostate Cancer
@en
P2093
Aaron Leiblich
Daniel Stevens
Prasanna Sooriakumaran
P2860
P2888
P356
10.1007/S11934-015-0573-Z
P407
P5008
P577
2016-03-01T00:00:00Z
P5875
P6179
1011998952